We are live on ! Find out more
OAM

Oxford Asset Management Portfolio holdings

AUM $232M
1-Year Est. Return 31%
This Fund
S&P 500
This Quarter Est. Return
+6.6%
1 Year Est. Return
+31%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.64B
AUM Growth
+$58.6M
Cap. Flow
-$75.7M
Cap. Flow %
-1.63%
Top 10 Hldgs %
8.11%
Holding
2,126
New
508
Increased
566
Reduced
535
Closed
464

Sector Composition

Rank Sector Weight
1 Industrials 15.25%
2 Consumer Discretionary 14.77%
3 Technology 14.01%
4 Healthcare 12.53%
5 Financials 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESTE
1626
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$75K ﹤0.01%
+12,275
New +$80.4K
ASXC
1627
DELISTED
Asensus Surgical, Inc.
ASXC
$73K ﹤0.01%
+4,154
New +$90.9K
ATHX
1628
DELISTED
Athersys, Inc. Common Stock
ATHX
$70K ﹤0.01%
1,661
+36
+2% +$1.47K
IBRX icon
1629
ImmunityBio
IBRX
$7.86B
$69K ﹤0.01%
67,696
-23,479
-26% -$27.1K
SEAC
1630
DELISTED
Seachange International Inc
SEAC
$69K ﹤0.01%
2,412
-2,743
-53% -$73.1K
GEN
1631
DELISTED
Genesis Healthcare, Inc.
GEN
$68K ﹤0.01%
54,626
-80,434
-60% -$102K
HCCHW
1632
DELISTED
HL Acquisitions Corp. Warrant
HCCHW
$65K ﹤0.01%
242,540
CYH icon
1633
Community Health Systems
CYH
$417M
$64K ﹤0.01%
24,054
-841,802
-97% -$2.66M
UPL
1634
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
$63K ﹤0.01%
351,383
-111,191
-24% -$47.6K
TA
1635
DELISTED
TravelCenters of America LLC
TA
$57K ﹤0.01%
+3,125
New +$59.9K
ALACW
1636
DELISTED
Alberton Acquisition Corp Warrant
ALACW
$56K ﹤0.01%
510,000
IFRX icon
1637
InflaRx
IFRX
$265M
$53K ﹤0.01%
16,685
-57,234
-77% -$1.81M
RVPHW
1638
DELISTED
Reviva Pharmaceuticals Warrants
RVPHW
$46K ﹤0.01%
217,600
-52,400
-19% -$10.5K
AVEO
1639
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$46K ﹤0.01%
+6,780
New +$58.1K
SRNE
1640
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$45K ﹤0.01%
+16,800
New +$60.5K
HHHHR
1641
DELISTED
Wealthbridge Acquisition Limited Rights
HHHHR
$45K ﹤0.01%
+225,000
New +$46.7K
MBIO icon
1642
Mustang Bio
MBIO
$4.26M
$43K ﹤0.01%
+16
New +$45.7K
TC
1643
TuanChe
TC
$51M
$42K ﹤0.01%
11
+1
+10% +$6.59K
DDMXW
1644
DELISTED
DD3 Acquisition Corp. Warrants
DDMXW
$41K ﹤0.01%
138,080
-121,920
-47% -$34.4K
SBBP
1645
DELISTED
Strongbridge Biopharma plc.
SBBP
$39K ﹤0.01%
+12,448
New +$45.7K
CNACW
1646
DELISTED
Constellation Alpha Capital Corp. Warrant
CNACW
$39K ﹤0.01%
530,800
TLPH icon
1647
Talphera
TLPH
$74.2M
$37K ﹤0.01%
+735
New +$44.1K
IMDX
1648
Insight Molecular Diagnostics
IMDX
$156M
$33K ﹤0.01%
+665
New +$55.3K
AMPE
1649
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$31K ﹤0.01%
+269
New +$42.6K
VBIV
1650
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$28K ﹤0.01%
+799
New +$43.3K

Similar funds

Oxford Asset Management's Q2 2019 Portfolio in Review

As of Q2 2019, Oxford Asset Management held 2,126 positions worth $4.64B, up 1.3% from $4.59B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Oxford Asset Management's Q2 2019 filing shows 508 new, 566 increased, 535 reduced and 464 closed positions. Its largest new stake was Medidata Solutions, Inc.: 526,177 shares worth $47.6M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $101M.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, up from 12% a quarter earlier, followed by Consumer Discretionary and Technology.

  • Oxford Asset Management's largest Q2 2019 buy was Medidata Solutions, Inc.: 526,177 shares worth $47.6M.
  • Oxford Asset Management added most to Shutterfly, Inc. in Q2 2019, an estimated $28.8M increase.
  • Oxford Asset Management's biggest Q2 2019 reduction was American Virtual Cloud Technologies, Inc. Common Stock, cutting an estimated $27.6M.
  • Oxford Asset Management fully exited iShares MSCI Emerging Markets ETF in Q2 2019, selling an estimated $101M.
  • Oxford Asset Management's ten largest holdings make up 8.1% of its $4.64B portfolio in Q2 2019.
  • Oxford Asset Management opened 508 new positions and closed 464 in Q2 2019.
  • Oxford Asset Management's portfolio value rose 1.3% quarter-over-quarter to $4.64B.

Based on Oxford Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.